Anti-PrLZ antibodies enable researchers to detect and measure the PrLZ antigen in biological samples. This target is a reported synonym of the TPD52 gene, which encodes tumor protein D52. This protein is known to function in the morphogenesis of anatomical structure and B cell differentiation, among other biological roles. The human version of PrLZ has a canonical amino acid length of 224 residues and a protein mass of 24.3 kilodaltons, although 8 isoforms have been identified. It is reported to be widely expressed in many tissue types. Other names for this target antigen include D52, N8L, and PC-1. Indicated applications for PrLZ antibodies listed below include ELISA, Western Blot, Immunoprecipitation, and Immunohistochemistry.